Stability of refrigerated miglustat after preparation in InOrpha® flavored suspending excipient for compounding of oral solutions and suspensions

• Päätekijät: Riahi S (Tekijä), Ambühl M (Tekijä), Stichler J (Tekijä), Bandilla D (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Dove Medical Press, 2015-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Sofyen Riahi, Michael Ambühl, Jürgen Stichler, Dirk Bandilla Actelion Pharmaceuticals Ltd, Allschwil, Switzerland Background: Miglustat (Zavesca®) is an oral treatment for type 1 Gaucher disease and Niemann–Pick disease type C. Patients with Niemann–Pick disease type C often have difficulties swallo...